MK-801, a high-affinity phencyclidine (PCP) analogue, is a non-competi
tive antagonist of the N-methyl-D-aspartate (NMDA) subclass of glutama
te receptor that elicits hyperactivity, stereotypic behaviors, and ''p
opping,'' an explosive episodic jumping behavior, in mice. The schizop
hreniform psychosis precipitated by PCP in humans has stimulated inter
est in studying MK-801-elicited mouse behaviors for their potential de
velopment as animal models of idiopathic psychosis. We describe a comp
uterized method for measuring popping and hyperactivity elicited by MK
-801 in mice, based on vertical displacements of a platform. This comp
uterized procedure allows for the automatic measurement of discrete ''
pops'' per individual episode of popping behavior, the force of each o
ne of the explosive jumps, and the duration of discrete episodes of po
pping; these latter measures could not be easily ascertained by visual
inspection alone. Moreover, the computerized measurements facilitate
quantitative evaluation of the effects of pharmacological manipulation
s on MK-801-elicited popping, For example, the antipsychotic haloperid
ol was shown to reduce significantly both MK-801-induced popping and h
yperactivity. Ideally, MK-801-elicited mouse popping and hyperactivity
will serve as a useful preclinical screening paradigm for potential a
ntipsychotic medications. Additionally, it is hoped that the use of th
is automated system will contribute to a greater understanding of the
mechanisms of MK-801-induced popping and hyperactivity.